{"nctId":"NCT00909870","briefTitle":"Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers","startDateStruct":{"date":"2009-06"},"conditions":["Venous Leg Ulcer"],"count":537,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Device: Dermagraft(R)"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Profore"]}],"interventions":[{"name":"Dermagraft(R)","otherNames":[]},{"name":"Profore","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* \\>18 years of age\n* ABI \\> 0.80\n* Three or fewer venous leg ulcers, if multiple must be separated by 2 cm\n* Ultrasound demonstrates venous reflux \\>0.5 seconds\n* Study wound present for 1-24 months\n* Study wound 2-15 sq cm surface area\n* Clean, granulating wound\n* Patient able and willing to sign informed consent and comply with study procedures.\n* Women of childbearing potential must use birth control pills, barriers or abstinence and have a negative pregnancy test.\n\nExclusion Criteria:\n\n* Wound etiology uncertain or not from venous hypertension.\n* BMI\\>40\n* Acute or chronic infectious skin disease\n* Allergy or intolerance to Profore(R)\n* Wound infection, cellulitis, osteomyelitis\n* \\>2 weeks' treatment with immunosuppressive agents in recent past\n* Investigational drug use within 30 days\n* Severe malnutrition, drug and/or alcohol abuse\n* Malignant disease unless in remission for 5 years\n* History of radiation at the study site\n* Other conditions that could impede wound healing\n* Known history of HIV or AIDS\n* Prior participation in any Dermagraft study\n* Treatment with other bioengineered tissue products within 30 days\n* Unable to understand the aims and objectives of the trial\n* Inability to comply with study protocol\n* NYHA Class III or IV CHF\n* Uncontrolled diabetes mellitus\n* Dorsal foot ulcer","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Complete Healing of the Study Ulcer by Week 16.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"201","spread":null},{"groupId":"OG001","value":"176","spread":null}]}]}]},{"type":"SECONDARY","title":"Time-to-Complete Healing","description":"Kaplan-Meier survival analysis of the time to achieve median (50%) Complete Healing response in each treatment group.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"58","spread":null},{"groupId":"OG001","value":"64","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Complete Healing by Week 16: Ulcers <= 12 Months Duration","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":null},{"groupId":"OG001","value":"132","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":28,"n":274},"commonTop":["Skin Ulcer","Infected skin ulcer","Pain in extremity","Excoriation","Nasopharyngitis"]}}}